Cargando…

Antibody–Drug Conjugates: The Last Decade

An armed antibody (antibody–drug conjugate or ADC) is a vectorized chemotherapy, which results from the grafting of a cytotoxic agent onto a monoclonal antibody via a judiciously constructed spacer arm. ADCs have made considerable progress in 10 years. While in 2009 only gemtuzumab ozogamicin (Mylot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Joubert, Nicolas, Beck, Alain, Dumontet, Charles, Denevault-Sabourin, Caroline
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7558467/ https://www.ncbi.nlm.nih.gov/pubmed/32937862 http://dx.doi.org/10.3390/ph13090245

Ejemplares similares

Intra-Domain Cysteines (IDC), a New Strategy for the Development of Original Antibody Fragment–Drug Conjugates (FDCs)
por: Jolivet, Louis, et al.
Publicado: (2022)

Internalization of Foldamer-Based DNA Mimics through a Site-Specific Antibody Conjugate to Target HER2-Positive Cancer Cells
por: Corvaglia, Valentina, et al.
Publicado: (2021)

Payload diversification: a key step in the development of antibody–drug conjugates
por: Conilh, Louise, et al.
Publicado: (2023)

In Vitro Characterization and Stability Profiles of Antibody–Fluorophore Conjugates Derived from Interchain Cysteine Cross-Linking or Lysine Bioconjugation
por: Martin, Camille, et al.
Publicado: (2019)

Monodisperse polysarcosine-based highly-loaded antibody-drug conjugates
por: Viricel, Warren, et al.
Publicado: (2019)

Antibody-drug conjugates: Present and future
por: Beck, Alain, et al.
Publicado: (2013)

Exatecan Antibody Drug Conjugates Based on a Hydrophilic Polysarcosine Drug-Linker Platform
por: Conilh, Louise, et al.
Publicado: (2021)

FDA-Approved Drugs for Hematological Malignancies—The Last Decade Review
por: Sochacka-Ćwikła, Aleksandra, et al.
Publicado: (2021)

Therapeutic antibodies – natural and pathological barriers and strategies to overcome them
por: Al Ojaimi, Yara, et al.
Publicado: (2022)

Review of Antibody-Drug Conjugates, Methods in Molecular Biology series: A book edited by Laurent Ducry
por: Beck, Alain
Publicado: (2014)

New drugs in cystic fibrosis: what has changed in the last decade?
por: Roda, Juliana, et al.
Publicado: (2022)

Fluorescence imaging in the last two decades
por: Miyawaki, Atsushi
Publicado: (2013)

Antibody-Oligonucleotide Conjugates: A Twist to Antibody-Drug Conjugates
por: Dugal-Tessier, Julien, et al.
Publicado: (2021)

Active SLAM: A Review on Last Decade
por: Ahmed, Muhammad Farhan, et al.
Publicado: (2023)

The Last Decade of Optically Active α-Aminophosphonates
por: Varga, Petra R., et al.
Publicado: (2023)

Introduction to Antibody-Drug Conjugates
por: Pettinato, Mark C.
Publicado: (2021)

Schizophrenia Research: Indian Scene in Last Decade
por: Avasthi, Ajit, et al.
Publicado: (2004)

Cannabis and psychopathology: The meandering journey of the last decade
por: Ghosh, Abhishek, et al.
Publicado: (2015)

Oligometastatic carcinoma prostate – An overview of the last decade
por: Shah, Milap J, et al.
Publicado: (2023)

Last Decade of Unconventional Methodologies for the Synthesis of Substituted Benzofurans
por: Chiummiento, Lucia, et al.
Publicado: (2020)

7-Isopentenyloxycoumarin: What Is New across the Last Decade
por: Preziuso, Francesca, et al.
Publicado: (2020)

Invertebrate Iridoviruses: A Glance over the Last Decade
por: İnce, İkbal Agah, et al.
Publicado: (2018)

Injectable Hydrogels for Cancer Therapy over the Last Decade
por: Cirillo, Giuseppe, et al.
Publicado: (2019)

Insights on Cellulose Research in the Last Two Decades in Romania
por: Coseri, Sergiu
Publicado: (2021)

Radioimmunotherapy in Oncology: Overview of the Last Decade Clinical Trials
por: Rondon, Aurélie, et al.
Publicado: (2021)

Laryngopharyngeal Reflux: The Last Decade
por: Karkos, Petros D., et al.
Publicado: (2022)

Antibody-drug conjugates: recent advances in conjugation and linker chemistries
por: Tsuchikama, Kyoji, et al.
Publicado: (2016)

Antibody–Drug Conjugates for Cancer Therapy
por: Hafeez, Umbreen, et al.
Publicado: (2020)

Antibody-Drug Conjugates in Bladder Cancer
por: Vlachostergios, Panagiotis J., et al.
Publicado: (2018)

Acquired Resistance to Antibody-Drug Conjugates
por: Collins, Denis M., et al.
Publicado: (2019)

Antibody–Drug Conjugates for Cancer Therapy
por: Parslow, Adam C., et al.
Publicado: (2016)

Clinical Pharmacology of Antibody-Drug Conjugates
por: Mahmood, Iftekhar
Publicado: (2021)

Mechanisms of Resistance to Antibody–Drug Conjugates
por: Abelman, Rachel Occhiogrosso, et al.
Publicado: (2023)

Mechanisms of Resistance to Antibody-Drug Conjugates
por: Khoury, Rita, et al.
Publicado: (2023)

The Potential of Topoisomerase Inhibitor-Based Antibody–Drug Conjugates
por: Han, Seungmin, et al.
Publicado: (2022)

Monoclonal Antibodies and Antibody Drug Conjugates in Multiple Myeloma
por: Radocha, Jakub, et al.
Publicado: (2021)

Integrated Raman Laser: A Review of the Last Two Decades
por: Ferrara, Maria Antonietta, et al.
Publicado: (2020)

Progress in the last decade in our understanding of primary progressive aphasia
por: Ratnavalli, Ellajosyula
Publicado: (2010)

The Development of Emotional Programmes in Education Settings during the Last Decade
por: Muñoz-Oliver, Beatriz, et al.
Publicado: (2022)

Insights into Dyslexia Genetics Research from the Last Two Decades
por: Erbeli, Florina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_va9pmqtjiea6asv4l7sc2vrs8p